pharmaphorum3 小时
UK biotech Swarm lands with a T-cell therapy mission
Swarm was formed in 2022 and has now emerged with Martin Olin – previously chief executive of BerGenBio and Symphogen – at ...
The Pharma Letter3 小时
Ex-Novo Nordisk director Martin Olin leads newly-formed Swarm
Swarm Oncology, a biotech developing novel T cell therapies to achieve long-term remission in patients with advanced solid ...
pharmaphorum3 小时
New UK biotech Swarm lands with T-cell therapy mission
Swarm was formed in 2022 and has now emerged with Martin Olin – previously chief executive of BerGenBio and Symphogen – at ...
Techno-Science on MSN12 小时
A powerful new weapon against cancer proves effective (sEVs) 🎯
A major breakthrough in the fight against cancer has just been achieved. An innovative method, successfully tested in the ...